
William G. Wright
Examiner (ID: 13821)
| Most Active Art Unit | 1106 |
| Art Unit(s) | 1106, 1754 |
| Total Applications | 637 |
| Issued Applications | 554 |
| Pending Applications | 0 |
| Abandoned Applications | 83 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12744454
[patent_doc_number] => 20180139985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => OXIDIZED CAROTENOIDS AND COMPONENTS THEREOF FOR PREVENTING NECROTIC ENTERITIS
[patent_app_type] => utility
[patent_app_number] => 15/570554
[patent_app_country] => US
[patent_app_date] => 2016-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12621
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570554
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/570554 | OXIDIZED CAROTENOIDS AND COMPONENTS THEREOF FOR PREVENTING NECROTIC ENTERITIS | Mar 1, 2016 | Abandoned |
Array
(
[id] => 16756543
[patent_doc_number] => 10975079
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives for use as BCRP inhibitors in therapeutic treatments
[patent_app_type] => utility
[patent_app_number] => 15/555152
[patent_app_country] => US
[patent_app_date] => 2016-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4388
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555152
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/555152 | 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives for use as BCRP inhibitors in therapeutic treatments | Feb 23, 2016 | Issued |
Array
(
[id] => 12675451
[patent_doc_number] => 20180116983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => COMPOUNDS FOR TREATING DISORDERS ASSOCIATED WITH BK CHANNEL MODULATION
[patent_app_type] => utility
[patent_app_number] => 15/550621
[patent_app_country] => US
[patent_app_date] => 2016-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26141
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550621
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550621 | COMPOUNDS FOR TREATING DISORDERS ASSOCIATED WITH BK CHANNEL MODULATION | Feb 11, 2016 | Abandoned |
Array
(
[id] => 12706642
[patent_doc_number] => 20180127380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => IMIDAZOLYL TRICYCLIC ENONES AS ANTIOXIDANT INFLAMMATION MODULATORS
[patent_app_type] => utility
[patent_app_number] => 15/548909
[patent_app_country] => US
[patent_app_date] => 2016-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548909
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/548909 | Imidazolyl tricyclic enones as antioxidant inflammation modulators | Feb 11, 2016 | Issued |
Array
(
[id] => 12151433
[patent_doc_number] => 20180022696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'NOVEL N-ACYL-ARYLSULFONAMIDE DERIVATIVES AS AMINOACYL-TRNA SYNTHETASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/550839
[patent_app_country] => US
[patent_app_date] => 2016-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23273
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550839
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550839 | N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitors | Feb 10, 2016 | Issued |
Array
(
[id] => 12150056
[patent_doc_number] => 20180021320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'Method of Preventing or Treating Hearing Loss'
[patent_app_type] => utility
[patent_app_number] => 15/550268
[patent_app_country] => US
[patent_app_date] => 2016-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9370
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550268
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550268 | Method of Preventing or Treating Hearing Loss | Feb 9, 2016 | Abandoned |
Array
(
[id] => 12217489
[patent_doc_number] => 20180055848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'Combination of Albuterol and Caffeine as Synergistic Treatment for Obesity or Sarcopenia'
[patent_app_type] => utility
[patent_app_number] => 15/565367
[patent_app_country] => US
[patent_app_date] => 2016-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9033
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15565367
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/565367 | Combination of Albuterol and Caffeine as Synergistic Treatment for Obesity or Sarcopenia | Jan 27, 2016 | Abandoned |
Array
(
[id] => 10790128
[patent_doc_number] => 20160136284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'GLIOMA TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/007834
[patent_app_country] => US
[patent_app_date] => 2016-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12848
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15007834
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/007834 | GLIOMA TREATMENT | Jan 26, 2016 | Abandoned |
Array
(
[id] => 11016673
[patent_doc_number] => 20160213626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'METHODS FOR MICROBIAL BIOFILM DESTRUCTION'
[patent_app_type] => utility
[patent_app_number] => 15/005905
[patent_app_country] => US
[patent_app_date] => 2016-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8028
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15005905
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/005905 | METHODS FOR MICROBIAL BIOFILM DESTRUCTION | Jan 24, 2016 | Abandoned |
Array
(
[id] => 12118689
[patent_doc_number] => 20180002275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'HYPDH INHIBITORS AND METHODS OF USE FOR THE TREATMENT OF KIDNEY STONES'
[patent_app_type] => utility
[patent_app_number] => 15/545818
[patent_app_country] => US
[patent_app_date] => 2016-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8354
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545818
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/545818 | HYPDH inhibitors and methods of use for the treatment of kidney stones | Jan 24, 2016 | Issued |
Array
(
[id] => 13714143
[patent_doc_number] => 20170368026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => PROMOTION OF HEALING OF INTESTINAL MUCOSA USING PROLINE, SERINE AND THREONINE
[patent_app_type] => utility
[patent_app_number] => 15/544066
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5524
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15544066
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/544066 | PROMOTION OF HEALING OF INTESTINAL MUCOSA USING PROLINE, SERINE AND THREONINE | Jan 21, 2016 | Abandoned |
Array
(
[id] => 13714145
[patent_doc_number] => 20170368027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => NUTRITIONAL COMPOSITION USEFUL IN THE TREATMENT OF IBD PATIENTS
[patent_app_type] => utility
[patent_app_number] => 15/544088
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15544088
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/544088 | Nutritional composition useful in the treatment of IBD patients | Jan 21, 2016 | Issued |
Array
(
[id] => 10789963
[patent_doc_number] => 20160136120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'TRANSDERMAL DELIVERY KITS'
[patent_app_type] => utility
[patent_app_number] => 15/003725
[patent_app_country] => US
[patent_app_date] => 2016-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6672
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15003725
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/003725 | TRANSDERMAL DELIVERY KITS | Jan 20, 2016 | Abandoned |
Array
(
[id] => 12125001
[patent_doc_number] => 20180008588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'ANTIHISTAMINE FOR USE IN TREATMENT OF BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/544575
[patent_app_country] => US
[patent_app_date] => 2016-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8650
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15544575
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/544575 | Antihistamine for use in treatment of breast cancer | Jan 18, 2016 | Issued |
Array
(
[id] => 13837473
[patent_doc_number] => 20190022221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => NON-INVASIVE SYSTEMS AND METHODS FOR TREATMENT OF A HOST CARRYING A VIRUS WITH PHOTOACTIVATABLE DRUGS
[patent_app_type] => utility
[patent_app_number] => 15/543297
[patent_app_country] => US
[patent_app_date] => 2016-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15543297
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/543297 | NON-INVASIVE SYSTEMS AND METHODS FOR TREATMENT OF A HOST CARRYING A VIRUS WITH PHOTOACTIVATABLE DRUGS | Jan 12, 2016 | Abandoned |
Array
(
[id] => 12448467
[patent_doc_number] => 09982008
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Preparation and uses of obeticholic acid
[patent_app_type] => utility
[patent_app_number] => 14/979005
[patent_app_country] => US
[patent_app_date] => 2015-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 70
[patent_no_of_words] => 36008
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14979005
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/979005 | Preparation and uses of obeticholic acid | Dec 21, 2015 | Issued |
Array
(
[id] => 11120574
[patent_doc_number] => 20160317547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'Male Contraceptive Compositions And Methods Of Use'
[patent_app_type] => utility
[patent_app_number] => 14/977343
[patent_app_country] => US
[patent_app_date] => 2015-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 24385
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14977343
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/977343 | Male contraceptive compositions and methods of use | Dec 20, 2015 | Issued |
Array
(
[id] => 10987379
[patent_doc_number] => 20160184325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'POLYHYDROXYLATED BILE ACIDS FOR TREATMENT OF BILIARY DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/976177
[patent_app_country] => US
[patent_app_date] => 2015-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16564
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14976177
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/976177 | Polyhydroxylated bile acids for treatment of biliary disorders | Dec 20, 2015 | Issued |
Array
(
[id] => 10820356
[patent_doc_number] => 20160166520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'METHODS AND COMPOSITIONS RELATING TO THE TREATMENT OF VISCERAL FAT AND ASTHMA'
[patent_app_type] => utility
[patent_app_number] => 14/969140
[patent_app_country] => US
[patent_app_date] => 2015-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 32055
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14969140
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/969140 | METHODS AND COMPOSITIONS RELATING TO THE TREATMENT OF VISCERAL FAT AND ASTHMA | Dec 14, 2015 | Abandoned |
Array
(
[id] => 12526734
[patent_doc_number] => 10005754
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Form of spirodiclofen, a process for its preparation and use the same
[patent_app_type] => utility
[patent_app_number] => 14/967950
[patent_app_country] => US
[patent_app_date] => 2015-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4831
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14967950
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/967950 | Form of spirodiclofen, a process for its preparation and use the same | Dec 13, 2015 | Issued |